中欧医疗创新股票C(006229)利润分配表
| |
2026-06-30 |
2025-12-31 |
2025-06-30 |
2024-12-31 |
| 收入 |
104,304,183.33 |
2,929,427,156.79 |
2,280,276,002.92 |
-1,583,779,244.53 |
| 利息合计 |
734,981.19 |
1,829,728.05 |
900,687.26 |
6,347,666.95 |
| 其中:存款利息收入 |
721,305.80 |
1,829,728.05 |
900,687.26 |
2,602,559.39 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
13,675.39 |
- |
- |
3,745,107.56 |
| 投资收益合计 |
-188,376,028.94 |
-543,853,602.92 |
-1,581,002,468.17 |
-2,724,525,881.89 |
| 其中:股票投资收益 |
-212,092,628.81 |
-583,612,603.71 |
-1,609,507,985.01 |
-2,802,557,260.52 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
346,441.39 |
829,342.03 |
634,890.51 |
2,273,075.32 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
23,370,158.48 |
38,929,658.76 |
27,870,626.33 |
75,758,303.31 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
287,861,662.31 |
3,450,024,976.50 |
3,851,535,573.69 |
1,127,543,772.08 |
| 其他收入 |
4,083,568.77 |
21,426,055.16 |
8,842,210.14 |
6,855,198.33 |
| 费用 |
58,895,140.16 |
142,024,937.19 |
66,498,259.81 |
133,775,273.96 |
| 管理人报酬 |
40,634,798.43 |
98,037,654.53 |
45,679,736.46 |
91,039,623.03 |
| 基金托管费 |
6,772,466.39 |
16,339,609.19 |
7,613,289.50 |
15,173,270.52 |
| 销售服务费 |
11,262,113.35 |
27,116,488.59 |
12,952,044.13 |
27,176,345.63 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
225,160.55 |
531,182.72 |
253,187.56 |
386,014.25 |
| 利润总额 |
45,409,043.17 |
2,787,402,219.60 |
2,213,777,743.11 |
-1,717,554,518.49 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年